{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:00:22Z","timestamp":1648656022355},"reference-count":12,"publisher":"Societas Neurologica Japonica","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5692\/clinicalneurol.54.22","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T23:11:07Z","timestamp":1389741067000},"page":"22-26","source":"Crossref","is-referenced-by-count":0,"title":["A case of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in which lomerizine hydrochloride was suggested to prevent recurrent stroke"],"prefix":"10.5692","volume":"54","author":[{"given":"Hisao","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Nagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) O\u2019Sullivan M, Jarosz JM, Martin RJ, et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001;56:628-634.","DOI":"10.1212\/WNL.56.5.628"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kim Y, Choi EJ, Choi CG, et al. Characteristics of CADASIL in Korea: a novel cysteine-sparing Notch3 mutation. Neurology 2006;66:1511-1516.","DOI":"10.1212\/01.wnl.0000216259.99811.50"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Mizuno T, Muranishi M, Torugun T, et al. Two Japanese CADASIL families exhibiting Notch3 mutation R75P not involving cysteine residue. Intern Med 2008;47:2067-2072.","DOI":"10.2169\/internalmedicine.47.1391"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Mizuno T, Kondo M, Ishigami N, et al. Cognitive impairment and cerebral hypoperfusion in a CADASIL patient improved during administration of lomerizine. Clin Neuropharmacol 2009;32:113-116.","DOI":"10.1097\/WNF.0b013e31816c82a6"},{"key":"5"},{"key":"6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Huang L, Yang Q, Zhang L, et al. Acetazolamide improves cerebral hemodynamics in CADASIL. J Neurol Sci 2010;292:77-80.","DOI":"10.1016\/j.jns.2010.01.023"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Pfefferkorn T, von Stuckrad-Barre S, Herzog J, et al. Reduced cerebrovascular CO(2) reactivity in CADASIL: A transcranial Doppler sonography study. Stroke 2001;32:17-21.","DOI":"10.1161\/01.STR.32.1.17"},{"key":"9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Viswanathan A, Guichard JP, Gschwendtner A, et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain 2006;129:2375-2383.","DOI":"10.1093\/brain\/awl177"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lesnik Oberstein SA, van den Boom R, van Buchem MA, et al. Cerebral microbleeds in CADASIL. Neurology 2001;57:1066-1070.","DOI":"10.1212\/WNL.57.6.1066"},{"key":"12"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u30ed\u30e1\u30ea\u30b8\u30f3\u6295\u4e0e\u306b\u3066\u8133\u6897\u585e\u6291\u5236\u52b9\u679c\u304c\u793a\u5506\u3055\u308c\u305fcerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy\uff08CADASIL\uff09\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T06:03:12Z","timestamp":1498111392000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/clinicalneurol\/54.22?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.54.22","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}